Profound Medical financials at a glance

+ Portfolio

The revenue of Profound Medical is reported as 0.00969 billion Dollars in the fiscal year 2023. The earnings were -1.82 Dollars per share in 2023, which was 5.2 lower than 2022. And about -0.03088 billion Dollars are reported as free cash flow in the financials of Profound Medical 2023. No dividends were paid to the shareholders of the Profound Medical stock TSX:PRN in the financial year 2023.

C$9.69M

Revenue

C$-1.82

Earnings Per Share

60.87%

Gross Margin %

C$-28.62M

Free Cash Flow

Revenue

9.69

Earnings Per Share

-1.82

Gross Margin %

60.87

Free Cash Flow

-28.62

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018	2017	2016	2015
Rev.	Revenue	N/A	C$9.69M	C$9.18M	C$8.71M	C$9.22M	C$5.53M	C$2.60M	C$4.90M	C$0.00M	C$0.00M
GM %	Gross Margin %	60.21%	60.87%	45.22%	42.95%	47.56%	57.26%	31.66%	38.18%	0.00%	0.00%
OM	Operating Margin	0.00%	0.00%	0.00%	0.00%	-,258.26%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	C$-1.39	C$-1.82	C$-1.73	C$-1.90	C$-1.58	C$-1.82	C$-2.10	C$-3.10	C$-3.90	C$-6.90
Div.	Dividends	N/A	C$0.00	C$0.00	C$0.00	C$0.00	C$0.00	C$0.00	C$0.00	C$0.00	C$0.00
PR %	Payout Ratio %	0	0	0	0	0	0	0	0	0	0
Sha.	Shares	N/AM	24.43M	20.91M	20.78M	20.29M	15.69M	10.81M	7.31M	5.53M	3.95M
OCF	Operating Cash Flow	N/A	C$-30.02M	C$-35.44M	C$-28.35M	C$-25.96M	C$-20.03M	C$-18.29M	C$-14.85M	C$-14.50M	C$0.00M
FCF	Free Cash Flow	N/A	C$-28.62M	C$-35.44M	C$-28.39M	C$-25.96M	C$-20.03M	C$-18.29M	C$-15.29M	C$-15.37M	C$0.00M
FCFS	Free Cash Flow Per Share	C$-1.04	C$-1.05	C$-1.24	C$-1.12	C$-1.21	C$-1.37	C$-1.82	C$-2.49	C$-3.76	C$-2.97

Profound Medical financials at a glance

Financials

Discover